Summary
Using a frozen section technique, we have assessed the effects of N-methyl-D-aspartate(NMDA) antagonist upon brain swelling caused by ischemic brain edema in a rat model of focal cerebral infarction. Although pretreatment with the competitive NMDA antagonist, D-CPPene or the noncompetitive NMDA antagonist, CNS 1102 reduced both the volumes of infarction and ischemic edema in the cerebral hemisphere, mean reduction in brain edema was proportionately similar to decrease in infarct volume in the same animals (correlation coefficienct, r = 0.82, p < 0.001). There was, therefore, no evidence of disproportionately greater effects with NMDA antagonist upon brain edema.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baethmann A, Oettinger W, Rothenfuer W, Kempski O, Unterberg A, Geiger R (1980) Brain edema factors: current state with particular reference to plasma constituents and glutamate. In: Cervós-Navarro J, Ferszt R (eds) Advances in neurology, vol 28. Raven, New York, pp 171–195
Bullock R, Graham D I, Chen M H, Lowe D, McCulloch J (1990) Focal cerebral ischemia in the cat: Pretreatment with a competitive NMDA receptor antagonist, D-CPPene. J Cereb Blood Flow Metab 10: 668–674
Germano I M, Pitts L H, Meldrum B S, Bartkowski H M, Simon RP (1987) Kynurenate inhibition of cell excitation decreases stroke size and deficits. Ann Neurol 22: 730–734
Gotti B, Duverger D, Bertin J, Carter C, Dupont R, Frost J, Gaudillier B, MacKenzie E T, Rousseau J, Scatton B, Wick A (1988) Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther 247: 1211–1221
Lowe D A, Neijt H C, Aebischer B (1990) D-CPPene (SDZz EAA 494), a potent and competitive N-methyl-D-aspartate (NMDA) antagonist: effect on spontaneous activity and NMDA-induced depolarizations in the rat neocortical slice preparation, compared with other CPP derivatives and MK-801. Neurosci Lett 113: 315–321
McBurney R N, Radd N L, Hamilton P N, Taylor E M, Cotter RE, Fischer J B, Goldin SM, Keana J F W, Wolcott T J, Kirk C J (1991) Neuroprotective efficacy of CNS 1102, a novel noncompetitive NMDA antagonist. J Cereb Blood Flow Metab 11 [Suppl2]:S219
McCulloch J, Bullock R, Teasdale G M (1991) Excitatory amino acid antagonists: opportunities for the treatment of ischemic brain damage in man. In: Meldrum BS (ed) Excitatory amino acid antagonists. Blackwell, Edinburgh, pp 287–327
Minematsu K, Fisher M, Li L, Kanapp A G, Cotter R E, McBurney R N, Sotak C H (1993) Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted Mri. Neurology 43: 397–403
Osborne K A, Shigeno T, Ford I, McCulloch J, Teasdale G M, Graham D I (1987) Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J Neurol Neurosurg Psychiatry 50: 402–410
Park C K, McBurney R N, Holt W F, Cotter R E, McCulloch J, Kang J K, Choi C R (1993) The dose-dependency of the antiischemic efficacy and of the side effects of a novel NMDA antagonist, CNS 1102. J Cereb Blood Flow Metab 13 [Suppl3]: S641
Park C K, McCulloch J, Kang J K, Choi C R (1992) Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat. Neursci Lett 147: 41–44
Park C K, Nehls D G, Graham D I, Teasdale G M, McCulloch J (1988) Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia. J Cereb Blood Flow Metab 8: 757–762
Park C K, Nehls D G, Graham D I, Teasdale GM, McCulloch J (1988) The glutamate antagonist MK-801 reduces focal ischaemic brain damage in the rat. Ann Neurol 24: 543–551
Rothman S M, Olney J W (1986) Glutamate and pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19: 105–111
Simon R, Shiraishi K (1990) N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism. Ann Neurol 27: 606–611
Simon R P, Swan J H, Griffiths T, Meldrum B S (1984) Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226: 850–883
Steinberg G K, George C P, DeLaPaz RD, Shibata D K, Gross T (1988) Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits. Stroke 19: 1112–1118
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag
About this paper
Cite this paper
Park, C.K., McCulloch, J., Jung, D.S., Kang, J.K., Choi, C.R. (1994). Do N-methyl-D-aspartate Antagonists Have Disproportionately Greater Effects on Brain Swelling than on Ischemic Damage in Focal Cerebral Infarction?. In: Ito, U., et al. Brain Edema IX. Acta Neurochirurgica, vol 60. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9334-1_74
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9334-1_74
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-9336-5
Online ISBN: 978-3-7091-9334-1
eBook Packages: Springer Book Archive